FOLH1 and prostate cancer: Interestingly, Kim et al. [20] showed that the use of different semiautomatic PET-derived tumor volume (PSMA-TV) models in patients with advanced prostate cancer predicts overall survival when comparing low and high-volume whole-body uptake.